Operating Expenses
Boston Scientific·Income Statement·8 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Other operating expenses | $2.3B | $2.2B | $2.4B | $2.3B | $2.6B | $2.5B | $2.9B | $2.5B |
| Total operating expenses | $2.3B | $2.2B | $2.4B | $2.3B | $2.6B | $2.5B | $2.9B | $2.5B |
| Selling, general and administrative | $1.4B | $1.6B | $1.6B | $1.6B | $1.7B | $1.7B | $1.8B | $1.8B |
| Amortization of Finite-Lived Intangible Assets | $213M | $205M | $225M | $219M | $225M | $225M | $228M | $232M |
| Amortization expense | $213M | $205M | $225M | $219M | $225M | $225M | $228M | $232M |
| Change in contingent consideration liability | $2M | -$23M | -$1M | $5M | -$5M | $11M | $7M | -$30M |
| Royalty expense | $9M | $5M | $9M | $14M | $14M | $12M | $6M | $12M |
| Restructuring charges | $1M | $8M | $4M | $10M | $83M | -$8M | $16M | $3M |